All Stories

  1. The efficacy of sapacitabine in treating patients with acute myeloid leukemia

    Article • Expert Opinion on Pharmacotherapy, September 2018, Taylor & Francis

    Prof Agnieszka Wierzbowska, Tadeusz Robak

  2. Decitabine improves response rate and prolongs progression-free survival in older patients with newly diagnosed acute myeloid leukemia and with monosomal karyotype: A subgroup analysis of the DACO-016 trial

    Article • American Journal of Hematology, February 2018, Wiley

    Prof Agnieszka Wierzbowska, Dr Albert Oriol

  3. Cladribine

    Article • American Journal of Hematology, February 2017, Wiley

    Prof Agnieszka Wierzbowska

  4. Post hoc analysis of the relationship between baseline white blood cell count and survival outcome in a randomized Phase III trial of decitabine in older patients with newly diagnosed acute myeloid leukemia

    Article • Journal of Blood Medicine, January 2015, Taylor & Francis

    Prof Grzegorz Mazur, Prof Agnieszka Wierzbowska